Tony Podany, PharmD

  • 213 Citations
  • 7 h-Index
20142020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tony Podany is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 213 Citations
  • 7 h-Index
  • 20 Article
  • 8 Review article

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review

Havens, J. P., Podany, A. T., Scarsi, K. K. & Fletcher, C. V., Feb 1 2020, In : Clinical Pharmacokinetics. 59, 2, p. 137-154 18 p.

Research output: Contribution to journalReview article

  • 1 Scopus citations
  • 1 Scopus citations

    Evaluating emtricitabine + rilpivirine + tenofovir alafenamide in combination for the treatment of HIV-infection

    Mu, Y., Pham, M., Podany, A. T. & Cory, T. J., Mar 3 2020, In : Expert Opinion on Pharmacotherapy. 21, 4, p. 389-397 9 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics

    Dyavar, S. R., Mykris, T. M., Winchester, L. C., Scarsi, K. K., Fletcher, C. V. & Podany, A. T., Dec 1 2020, In : Scientific reports. 10, 1, 12565.

    Research output: Contribution to journalArticle

    Open Access
  • High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

    The AIDS Clinical Trials Group and the Tuberculosis Trials Consortium, Mar 2020, In : Contemporary Clinical Trials. 90, 105938.

    Research output: Contribution to journalArticle

  • 1 Scopus citations